PRVA

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,782

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.83 to $39.82 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · derivative · entry 7

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,698,052

Underlying: Common Stock · 31,235 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,839,197 of the stock options were fully vested and exercisable.890,090 of the stock options vest on October 29, 2022

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 3

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.10 to $39.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 2

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,554

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.10 to $39.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000126 · wf-form4_166266757775965.xml · derivative · entry 3

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,037

Underlying: Common Stock · 12,862 shares

Expires 2028-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transaction reported in this Form 4, 38,380 of the stock options are fully vested and exercisable. 25,519 will vest on October 29, 2022.

SEC source: 0001759655-22-000126 · wf-form4_166266757775965.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,195

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.

SEC source: 0001759655-22-000126 · wf-form4_166266757775965.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · derivative · entry 11

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,729,287

Underlying: Common Stock · 66,809 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,974,108 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 9

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.91 to $42.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 8

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,439

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.90 to $41.83 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 7

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,013

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.86 to $40.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 6

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,613

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.86 to $39.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · derivative · entry 10

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,796,096

Underlying: Common Stock · 68,102 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,974,108 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.43 to $43.59 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 3

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,339

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.41 to $43.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 2

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,957

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000122 · wf-form4_166180388653559.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · derivative · entry 8

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,864,198

Underlying: Common Stock · 44,183 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,110,116 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 6

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.50 to $35.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,478

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.50 to $35.49 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · derivative · entry 7

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,908,381

Underlying: Common Stock · 91,825 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,110,116 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 3

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.70 to $37.21 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 2

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,909

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.70 to $36.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000120 · wf-form4_166077148340494.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000113 · wf-form4_166000134769217.xml · derivative · entry 3

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,899

Underlying: Common Stock · 63,694 shares

Expires 2028-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transaction reported in this Form 4, 102,074 of the stock options are fully vested and exercisable. 25,519 will vest on October 29, 2022.

SEC source: 0001759655-22-000113 · wf-form4_166000134769217.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,492

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.45 to $38.07 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000113 · wf-form4_166000134769217.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · derivative · entry 5

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,345,692

Underlying: Common Stock · 100,000 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,172,133 of the stock options are fully vested and exercisable.273,559 of the stock options will vest on October 29, 2022.

SEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 4

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.65 to $38.71 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,442

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.65 to $38.64 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,216

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.65 to $37.64 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000138 · wf-form4_166423154218441.xml · nonDerivative · entry 1

Butler Jeffrey B · CIK 0001859428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,459,637

F1 · kind: On July 25, 2022, the reporting person transferred 200,000 shares of the Issuer's common stock to the Butler Ventures Fund, Inc., a charitable foundation of which the reporting person and his spouse are directors. The reporting person has voting and investment power over the securities owned by the foundation.

SEC source: 0001759655-22-000108 · wf-form4_165877985244243.xml · derivative · entry 3

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,488

Underlying: Common Stock · 7,324 shares

Expires 2029-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 24,568 of the stock options are fully vested and exercisable. 17,244 of the stock options will vest on October 29, 2022.

SEC source: 0001759655-22-000108 · wf-form4_165877985244243.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,392

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.96 to $36.65 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000108 · wf-form4_165877985244243.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · derivative · entry 8

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000,206

Underlying: Common Stock · 120,589 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,343,688 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022.

SEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 6

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.35 to $34.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,537

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.35 to $34.34 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000104 · wf-form4_165843617238334.xml · derivative · entry 4

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,300

Underlying: Common Stock · 15,000 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 285,198 of the stock options are fully vested and exercisable. 64,102 of the stock options will vest on October 29, 2022.

SEC source: 0001759655-22-000104 · wf-form4_165843617238334.xml · nonDerivative · entry 3

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,355

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.50 to $34.60 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000104 · wf-form4_165843617238334.xml · nonDerivative · entry 2

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,785

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.46 to $34.45 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-22-000104 · wf-form4_165843617238334.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · derivative · entry 4

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,445,692

Underlying: Common Stock · 60,000 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,232,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022.

SEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.41 to $34.61 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.